FDA Inspection 1278839 — C.P.M. Contract Pharma GmbH & Co. KG

C.P.M. Contract Pharma GmbH & Co. KG — FEI 3005466331

The FDA completed an inspection of C.P.M. Contract Pharma GmbH & Co. KG on December 8, 2022 in Feldkirchen-Westerham. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 8, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Feldkirchen-Westerham (Germany)

Additional Details

Mutual Recognition Agreement (MRA)